Publications

Mitochondria-Targeted Antioxidant Antioxben2 Prevents Metabolic Dysfunction-Associated Steatotic Liver Disease (Masld) by Enhancing Fatty Acid Oxidation and Mitochondrial Bioenergetics

AuthID
P-01B-6KB

Author(s)

Amorim, R

Magalhães, C

Duarte, AI

de Lemos, C

Carvalho, A

Pereira, P

Grilo, F

Mena, D

Gerardo, H

Veloso, C

Sousa, D

Caseiro, AJ

Cagide Fagín, F

Borges, F

Matafome, P

Teixeira, J

Oliveira, J

Document Type

Article

Year published

2026

Published

in Biomedicine and Pharmacotherapy, ISSN: 0753-3322

Pages: 119022

Indexing

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.biopha.2026.119022

Pubmed: 41611610

Scopus: 2-s2.0-105029372548

Source Identifiers

ISSN: 0753-3322

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Mitochondria-Targeted Antioxidant Antioxben2 Prevents Metabolic Dysfunction-Associated Steatotic Liver Disease (Masld) by Enhancing Fatty Acid Oxidation and Mitochondrial Bioenergetics

Useful Links

Get Help

Federated Authentication (Click on the image)

Mitochondria-Targeted Antioxidant Antioxben2 Prevents Metabolic Dysfunction-Associated Steatotic Liver Disease (Masld) by Enhancing Fatty Acid Oxidation and Mitochondrial Bioenergetics

Useful Links

Get Help